Generated by AI
iRhythm Holdings, Inc. is a digital healthcare company focused on ambulatory cardiac monitoring and arrhythmia detection. The company develops and commercializes wearable, device-based technology that helps clinicians capture and analyze heart rhythm data outside of the hospital setting. Its product portfolio includes remote ECG monitoring systems and connected software tools that support physician review, patient data collection, and clinical workflow management. iRhythm Holdings serves cardiology, electrophysiology, primary care, and other specialty practices that rely on timely rhythm assessment to guide diagnosis. The company’s platform combines biosensors, cloud-based analytics, and proprietary algorithms to turn long-duration heartbeat data into clinically useful reports. Headquartered in San Francisco, iRhythm Holdings operates in the healthcare technology and medical devices market, where it plays a specialized role in noninvasive cardiac diagnostics.
Website699 8th Street
San Francisco, CA, 94103
United States
The latest articles about IRTC.
Summary of Jun 15's posts. Generated by AI.
Summary of Jan 14's posts. Generated by AI.
Summary of Mar 5's posts. Generated by AI.
Summary of Aug 4's posts. Generated by AI.
Investors talking about IRTC also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.